Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

FRG2B Inhibitors

The development of FRG2B inhibitors would involve a multi-faceted research approach to understand the detailed mechanism by which these compounds exert their inhibitory effect. Initial studies would likely include binding assays to demonstrate direct interaction between the inhibitors and the FRG2B protein. Advanced techniques such as X-ray crystallography or nuclear magnetic resonance (NMR) spectroscopy could be employed to elucidate the three-dimensional structure of the protein in complex with the inhibitors, providing insights into the binding sites and the structural basis for inhibition. Furthermore, the specificity of the compounds would be a significant focus to ensure that they do not cross-react with other proteins, which is essential to clearly define the role of FRG2B. Subsequent studies might investigate the impact of the inhibitors on the cellular and molecular pathways in which FRG2B is implicated, thereby revealing the biological processes that are modulated by this protein.

The exploration of FRG2B inhibitors would play a crucial role in advancing our understanding of the biological function of the FRG2B protein. By selectively modulating the activity of FRG2B, researchers could observe the resulting changes in cellular behavior and molecular pathways, thus uncovering the protein's role within the cell. Such studies would provide broader insights into the cellular functions associated with FRG2B and could highlight its involvement in complex biological systems. Additionally, research into FRG2B inhibition could contribute to the field of protein-protein interactions and the regulatory mechanisms that control gene expression, potentially shedding light on the orchestration of cellular events that rely on such proteins. Overall, this research would enhance our fundamental knowledge of cellular biology and the molecular underpinnings of protein function.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Triptolide

38748-32-2sc-200122
sc-200122A
1 mg
5 mg
$90.00
$204.00
13
(1)

Triptolide is known to inhibit the transcription of a wide range of genes by interfering with RNA polymerase II activity.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin inhibits mTOR, which can downregulate protein synthesis and potentially affect the expression of numerous genes.

Quercetin

117-39-5sc-206089
sc-206089A
sc-206089E
sc-206089C
sc-206089D
sc-206089B
100 mg
500 mg
100 g
250 g
1 kg
25 g
$11.00
$17.00
$110.00
$250.00
$936.00
$50.00
33
(2)

Quercetin has been shown to modulate various signaling pathways and may influence gene expression indirectly.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

EGCG can modulate several signaling pathways and transcription factors, potentially altering gene expression.

Rocaglamide

84573-16-0sc-203241
sc-203241A
sc-203241B
sc-203241C
sc-203241D
100 µg
1 mg
5 mg
10 mg
25 mg
$275.00
$474.00
$1639.00
$2497.00
$5344.00
4
(1)

Rocaglamide inhibits translation initiation and could decrease the expression of many proteins, including hypothetical "FRG2B".

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

Retinoic acid affects gene expression by activating nuclear receptors, potentially downregulating certain genes.

Mycophenolic acid

24280-93-1sc-200110
sc-200110A
100 mg
500 mg
$69.00
$266.00
8
(1)

It inhibits inosine monophosphate dehydrogenase, which may lead to reduced proliferation and altered gene expression.

Oxamflatin

151720-43-3sc-205960
sc-205960A
1 mg
5 mg
$151.00
$470.00
4
(1)

Oxamflatin is an HDAC inhibitor that can alter chromatin structure and affect gene expression globally.

1-β-D-Arabinofuranosylcytosine

147-94-4sc-201628
sc-201628A
sc-201628B
sc-201628C
sc-201628D
1 g
5 g
25 g
100 g
250 g
$150.00
$263.00
$518.00
$731.00
$1461.00
1
(1)

1-β-D-Arabinofuranosylcytosine is a nucleoside analog that can be incorporated into DNA, potentially affecting DNA replication and gene expression.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Bortezomib inhibits the proteasome, leading to accumulation of regulatory proteins and potential changes in gene expression.